about
Variable expressivity familial cherubism: woman transmitting cherubism without suffering the disease.The use of topical corticosteroides in the treatment of oral lichen planus in Spain: A national surveyBlood loss in orthognathic surgery: a systematic review.An analysis of oral biopsies extracted from 1995 to 2009, in an oral medicine and surgery unit in Galicia (Spain).Peripheral giant-cell granuloma. Review of 13 cases.Osteonecrosis of the jaws in 194 patients who have undergone intravenous bisphosphonate therapy in Spain.Dexketoprofen/tramadol: randomised double-blind trial and confirmation of empirical theory of combination analgesics in acute pain.Applications of exfoliative cytology in the diagnosis of oral cancer.Cancer: undifferentiation or specialization?Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in SpainDental implants placed on bone subjected to vertical alveolar distraction show the same performance as those placed on primitive bone.Prognostic significance of monocarboxylate transporter expression in oral cavity tumors.Orthokeratinized odontogenic cyst: a report of three clinical casesComparison of RNA Extraction Methods for Molecular Analysis of Oral Cytology.Role of V-ATPases in solid tumors: importance of the subunit C (Review).Ultrasonic osteotomy in oral surgery and implantology.V-ATPase inhibitors and implication in cancer treatment.Genetic and molecular alterations associated with oral squamous cell cancer (Review).Exfoliative cytology for diagnosing oral cancer.Beta-adrenergic receptors in cancer: therapeutic implications.p16(INK4a)/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough?What real influence does the proto-oncogene c-myc have in OSCC behavior?The role of the adenomatous polyposis coli (APC) in oral squamous cell carcinoma.Hypoxia-inducible factors in OSCC.Current trends in miRNAs and their relationship with oral squamous cell carcinoma.Epigenome and DNA methylation in oral squamous cell carcinoma.The role of carbonic anhydrase IX in hypoxia control in OSCC.An update in the structure, function, and regulation of V-ATPases: the role of the C subunit.Tissue inhibitor of metalloproteinases in oral squamous cell carcinomas - a therapeutic target?Accidental displacement and migration of endosseous implants into adjacent craniofacial structures: a review and update.Expression of CA IX in dysplasia adjacent to surgical resection margins of oral squamous cell carcinoma.p27(Kip1) expression as a prognostic marker for squamous cell carcinoma of the head and neck.Expression of ATP6V1C1 during oral carcinogenesis.Correlation of Beta-2 Adrenergic Receptor Expression in Tumor-Free Surgical Margin and at the Invasive Front of Oral Squamous Cell Carcinoma.Inhibition of V-ATPase and carbonic anhydrases as interference strategy with tumor acidification processes.Dental anxiety before removal of a third molar and association with general trait anxiety.Pederson scale fails to predict how difficult it will be to extract lower third molars.Histopathological findings in oral lichen planus and their correlation with the clinical manifestations.Comparison of three sampling instruments, Cytobrush, Curette and OralCDx, for liquid-based cytology of the oral mucosa.Immunohistochemical localization of C1 subunit of V-ATPase (ATPase C1) in oral squamous cell cancer and normal oral mucosa.
P50
Q30009506-A8AF4839-0CCB-4742-9C5C-6CF4F978927EQ33688007-7F1340E1-B969-422E-8D37-1FFBD95913E8Q33783089-EA6228C0-6063-411D-B780-4A7AF0B61D8DQ34630928-ABA93642-55BA-465B-91E2-95C77F1F44ADQ34755112-A00378B7-D074-47B9-93A3-B639AE771871Q35732126-07575CF7-066C-4287-81B8-0E5AD5D56DC3Q35798596-298B8C69-6888-4631-86DF-D8AEF57C799BQ35855425-F271686C-2BBD-4A76-B113-9D9E4C18AD3AQ36173418-01950D2D-B508-46FE-B6E0-FBD290653904Q36351542-A5547F68-C64D-4AE0-A644-7F73F5B74800Q37063597-F17C313F-9456-4B62-90FE-122B43B34103Q37143080-10D6D4DC-3CD0-4E42-B350-E6DD45D9B682Q37244391-5FF553A6-3F62-4EC3-B6A5-86EE970EB510Q37366839-05C657AA-AD22-4F36-80BC-90C0A827E6ACQ37474425-35C051D9-86E9-43F7-844A-9D9674CD3EC3Q37537887-C3A7AAA5-CE90-406E-ABF5-7E685AADDE8BQ37598445-2F2DF84D-7DE9-46B4-8958-92BC1B529D4DQ37626579-67C263EF-128E-42E6-9987-96C993C85F26Q37738892-A8DC7B5F-7587-4BF1-8751-27F17C7AB644Q37818101-8DE0B53E-D364-4B6E-8825-D00E13E09DF6Q37853701-3141138C-3281-4B9C-B200-E14C749F040CQ37894963-7A075805-9344-4F7C-9F25-CB1D3ABEA4F6Q37936654-A1E42847-97EF-4C67-9CED-5E5A1514A061Q37940756-438D0B30-5051-4132-8F86-44C98C470656Q37970449-7C43523C-B533-4874-8F92-2C6E3340B28FQ37987508-B5CF9B9B-15E6-40F9-978B-58B4F6DF9589Q37993617-DBC23F18-8B98-4A95-A3ED-BEC7A424CCE1Q37995893-D8D09966-66FE-4959-9094-D3C5A2A35B36Q38000930-B8589E04-1419-4503-AFF5-9853CFBBD057Q38006874-2F250068-D8BF-4304-83E3-5053A67C3B10Q38395239-66AE486E-F88D-4FF4-9524-DF2F846510AEQ38684614-AC0D8C75-199F-4431-B71C-E0E808C94C9EQ38894217-30D49125-1F74-40C6-BB0B-B8D6834B0F7FQ39025038-3C912693-1065-42FE-944E-5B618E4DDB4FQ39648809-AB314CE1-14AF-4A2E-97FA-6371B6103CF9Q40296719-C8EDA932-652C-4584-813E-5D887CDFF580Q40356050-501D3171-9C04-4E9C-ACB1-108A7CB7BD51Q42475770-221CA130-CB40-4CDC-B1B3-3162F727549FQ42484302-2AF57D75-F0F4-4FED-A97E-A1AB95FB1394Q42487320-B4CE0BC6-992F-41C3-89D8-577EA5048B96
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Abel García-García
@ast
Abel García-García
@en
Abel García-García
@es
Abel García-García
@nl
Abel García-García
@sl
type
label
Abel García-García
@ast
Abel García-García
@en
Abel García-García
@es
Abel García-García
@nl
Abel García-García
@sl
altLabel
A Garcia
@en
A Garcia-Garcia
@en
Abel Garcia
@en
Garcia AG
@en
prefLabel
Abel García-García
@ast
Abel García-García
@en
Abel García-García
@es
Abel García-García
@nl
Abel García-García
@sl
P106
P1153
7005668113
P21
P214
9880153411860341700009
P31
P496
0000-0002-5911-5537
P7859
viaf-9880153411860341700009